| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $4.16M | $19.35M | $48.45M | $45.49M | $30.40M |
| R&D | $445.51K | $11.85M | $35.64M | $33.27M | $20.40M |
| SG&A | $3.32M | $7.50M | $9.62M | $10.35M | $10.01M |
| Operating Income | -$4.16M | -$19.35M | -$48.45M | -$45.49M | -$30.40M |
| Interest Expense | – | – | $9.46K | $10.16K | $8.86K |
| Tax Expense | – | -$2.97M | -$409.02K | -$2.88M | $0.00 |
| Net Income | -$8.28M | -$13.19M | -$48.93M | -$42.20M | -$32.72M |
| EPS (basic) | -0.8800 | -107.3500 | -12.3200 | -0.5900 | -0.4700 |
| EPS (diluted) | -0.8800 | -107.3500 | -12.3200 | -0.5900 | -0.4700 |
| Shares (diluted) | $9.41M | $122.89K | $3.97M | $76.23M | $70.29M |